Skip to main content
BDX
NYSE Life Sciences

贝克顿迪金森股价暴跌26%:第四季度收入未达预期、下调预测

feedReported by Wiseek News
Sentiment info
Negative
Importance info
9
Price
$154.22
Mkt Cap
$43.913B
52W Low
$127.536
52W High
$187.35
Market data snapshot near publication time

summarizeSummary

贝克顿迪金森(BDX)报告第四季度收入为449亿美元,未达预期,并且全年每股收益(EPS)也未达预期。市场做出了激烈反应,股价在公告后大约下跌了26%。这种重大财务表现不佳代表了对投资者的重大负面惊喜,可能影响未来增长预测和市场估值。这则消息还重申了计划于4月9日在一份8-K文件中披露的干预部门执行副总裁和总裁Rick Byrd的退休计划。交易者将密切关注管理层对收入未达预期的解释以及任何更新的前景预测。

在该公告发布时,BDX的交易价格为$154.22,交易所为NYSE,所属行业为Life Sciences,市值约为$439.1亿。 52周交易区间为$127.54至$187.35。 这则新闻被评估为消极市场情绪,重要性评分为9/10。 来源:Wiseek News。


show_chartPrice Chart

Share this article

Copied!

feed BDX - Latest Insights

BDX
Apr 10, 2026, 4:05 PM EDT
Source: Wiseek News
Importance Score:
9
BDX
Apr 09, 2026, 4:18 PM EDT
Filing Type: 8-K
Importance Score:
7
BDX
Apr 02, 2026, 4:18 PM EDT
Filing Type: 8-K
Importance Score:
7
BDX
Feb 25, 2026, 4:25 PM EST
Filing Type: 8-K
Importance Score:
8
BDX
Feb 10, 2026, 4:16 PM EST
Filing Type: 8-K
Importance Score:
8
BDX
Feb 09, 2026, 4:19 PM EST
Filing Type: 10-Q
Importance Score:
7
BDX
Feb 09, 2026, 4:18 PM EST
Filing Type: 8-K
Importance Score:
9
BDX
Feb 09, 2026, 6:31 AM EST
Filing Type: 8-K
Importance Score:
7
BDX
Feb 05, 2026, 4:21 PM EST
Filing Type: 8-K
Importance Score:
7
BDX
Feb 05, 2026, 4:17 PM EST
Filing Type: 8-K
Importance Score:
7